US Capitol Capsule: Rare Diseases: The Path To Precision Medicine
This article was originally published in Scrip
Executive Summary
The path to achieving the promise of precision medicine – prevention and treatment strategies that take individual variability in genes, environment and lifestyle into account – must go through the discovery, research and development processes of rare diseases, a panel of experts and advocates said last week during a Capitol Hill briefing hosted by the House Rare Disease Congressional Caucus, headed by Reps. Leonard Lance (R-NJ) and Joe Crowley (D-NY).